Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:00:45 UTC
Update Date2020-02-26 21:39:19 UTC
HMDB IDHMDB0013991
Secondary Accession Numbers
  • HMDB13991
Metabolite Identification
Common Name5'-Hydroxylornoxicam
Description5'-Hydroxylornoxicam belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. 5'-Hydroxylornoxicam is a strong basic compound (based on its pKa).
Structure
Data?1582753159
Synonyms
ValueSource
6-Chloro-4-hydroxy-N-(5-hydroxypyridin-2-yl)-2-methyl-1,1-dioxo-2H-1λ⁶-thieno[2,3-e][1,2]thiazine-3-carboximidateGenerator
5'-HydroxylornoxicamMeSH
Chemical FormulaC13H10ClN3O5S2
Average Molecular Weight387.819
Monoisotopic Molecular Weight386.975039532
IUPAC Name6-chloro-4-hydroxy-N-(5-hydroxypyridin-2-yl)-2-methyl-1,1-dioxo-2H-1λ⁶-thieno[2,3-e][1,2]thiazine-3-carboxamide
Traditional Name6-chloro-4-hydroxy-N-(5-hydroxypyridin-2-yl)-2-methyl-1,1-dioxo-1λ⁶-thieno[2,3-e][1,2]thiazine-3-carboxamide
CAS Registry NumberNot Available
SMILES
CN1C(C(=O)NC2=CC=C(O)C=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O
InChI Identifier
InChI=1S/C13H10ClN3O5S2/c1-17-10(13(20)16-9-3-2-6(18)5-15-9)11(19)12-7(24(17,21)22)4-8(14)23-12/h2-5,18-19H,1H3,(H,15,16,20)
InChI KeyNQOMZUZLRFQVLR-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentAlpha amino acids and derivatives
Alternative Parents
Substituents
  • Alpha-amino acid or derivatives
  • Thienothiazine
  • N-arylamide
  • 2,3,5-trisubstituted thiophene
  • Hydroxypyridine
  • Ortho-thiazine
  • Aryl chloride
  • Aryl halide
  • Organosulfonic acid amide
  • Pyridine
  • Imidolactam
  • Organic sulfonic acid or derivatives
  • Organosulfonic acid or derivatives
  • Vinylogous acid
  • Thiophene
  • Heteroaromatic compound
  • Secondary carboxylic acid amide
  • Carboxamide group
  • Azacycle
  • Organoheterocyclic compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organochloride
  • Organohalogen compound
  • Hydrocarbon derivative
  • Carbonyl group
  • Organic oxide
  • Organopnictogen compound
  • Organic nitrogen compound
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.14 g/LALOGPS
logP2.63ALOGPS
logP0.33ChemAxon
logS-3.4ALOGPS
pKa (Strongest Acidic)1.76ChemAxon
pKa (Strongest Basic)4.14ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area119.83 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity89.88 m³·mol⁻¹ChemAxon
Polarizability35.59 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+177.42330932474
DeepCCS[M-H]-175.06530932474
DeepCCS[M-2H]-208.72230932474
DeepCCS[M+Na]+183.94930932474
AllCCS[M+H]+181.132859911
AllCCS[M+H-H2O]+178.332859911
AllCCS[M+NH4]+183.732859911
AllCCS[M+Na]+184.532859911
AllCCS[M-H]-177.332859911
AllCCS[M+Na-2H]-177.232859911
AllCCS[M+HCOO]-177.132859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
5'-HydroxylornoxicamCN1C(C(=O)NC2=CC=C(O)C=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O5542.7Standard polar33892256
5'-HydroxylornoxicamCN1C(C(=O)NC2=CC=C(O)C=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O3035.8Standard non polar33892256
5'-HydroxylornoxicamCN1C(C(=O)NC2=CC=C(O)C=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O3209.6Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
5'-Hydroxylornoxicam,1TMS,isomer #1CN1C(C(=O)NC2=CC=C(O[Si](C)(C)C)C=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O3326.6Semi standard non polar33892256
5'-Hydroxylornoxicam,1TMS,isomer #2CN1C(C(=O)NC2=CC=C(O)C=N2)=C(O[Si](C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3222.5Semi standard non polar33892256
5'-Hydroxylornoxicam,1TMS,isomer #3CN1C(C(=O)N(C2=CC=C(O)C=N2)[Si](C)(C)C)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O3197.1Semi standard non polar33892256
5'-Hydroxylornoxicam,2TMS,isomer #1CN1C(C(=O)NC2=CC=C(O[Si](C)(C)C)C=N2)=C(O[Si](C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3308.0Semi standard non polar33892256
5'-Hydroxylornoxicam,2TMS,isomer #2CN1C(C(=O)N(C2=CC=C(O[Si](C)(C)C)C=N2)[Si](C)(C)C)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O3216.2Semi standard non polar33892256
5'-Hydroxylornoxicam,2TMS,isomer #3CN1C(C(=O)N(C2=CC=C(O)C=N2)[Si](C)(C)C)=C(O[Si](C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3172.9Semi standard non polar33892256
5'-Hydroxylornoxicam,3TMS,isomer #1CN1C(C(=O)N(C2=CC=C(O[Si](C)(C)C)C=N2)[Si](C)(C)C)=C(O[Si](C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3266.7Semi standard non polar33892256
5'-Hydroxylornoxicam,3TMS,isomer #1CN1C(C(=O)N(C2=CC=C(O[Si](C)(C)C)C=N2)[Si](C)(C)C)=C(O[Si](C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3409.3Standard non polar33892256
5'-Hydroxylornoxicam,3TMS,isomer #1CN1C(C(=O)N(C2=CC=C(O[Si](C)(C)C)C=N2)[Si](C)(C)C)=C(O[Si](C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3980.4Standard polar33892256
5'-Hydroxylornoxicam,1TBDMS,isomer #1CN1C(C(=O)NC2=CC=C(O[Si](C)(C)C(C)(C)C)C=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O3566.4Semi standard non polar33892256
5'-Hydroxylornoxicam,1TBDMS,isomer #2CN1C(C(=O)NC2=CC=C(O)C=N2)=C(O[Si](C)(C)C(C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3502.2Semi standard non polar33892256
5'-Hydroxylornoxicam,1TBDMS,isomer #3CN1C(C(=O)N(C2=CC=C(O)C=N2)[Si](C)(C)C(C)(C)C)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O3456.4Semi standard non polar33892256
5'-Hydroxylornoxicam,2TBDMS,isomer #1CN1C(C(=O)NC2=CC=C(O[Si](C)(C)C(C)(C)C)C=N2)=C(O[Si](C)(C)C(C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3743.0Semi standard non polar33892256
5'-Hydroxylornoxicam,2TBDMS,isomer #2CN1C(C(=O)N(C2=CC=C(O[Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O3677.4Semi standard non polar33892256
5'-Hydroxylornoxicam,2TBDMS,isomer #3CN1C(C(=O)N(C2=CC=C(O)C=N2)[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3620.4Semi standard non polar33892256
5'-Hydroxylornoxicam,3TBDMS,isomer #1CN1C(C(=O)N(C2=CC=C(O[Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O3876.1Semi standard non polar33892256
5'-Hydroxylornoxicam,3TBDMS,isomer #1CN1C(C(=O)N(C2=CC=C(O[Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O4115.2Standard non polar33892256
5'-Hydroxylornoxicam,3TBDMS,isomer #1CN1C(C(=O)N(C2=CC=C(O[Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C2=C(C=C(Cl)S2)S1(=O)=O4094.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 5'-Hydroxylornoxicam GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4l-2963000000-bbbf20a677fb358ff93e2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 5'-Hydroxylornoxicam GC-MS (2 TMS) - 70eV, Positivesplash10-052f-5893110000-2cc3fc9af4671980664d2017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 5'-Hydroxylornoxicam GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 10V, Positive-QTOFsplash10-0a4r-0904000000-89200c734dec921b9daf2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 20V, Positive-QTOFsplash10-0a4i-0900000000-d40926e2f11abf9a64e72016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 40V, Positive-QTOFsplash10-0a4i-6900000000-dabba3b18b356d3dcb9a2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 10V, Negative-QTOFsplash10-000i-0319000000-c2641f05496434a85a312016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 20V, Negative-QTOFsplash10-0udi-1692000000-85425d685a5770c9fc762016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 40V, Negative-QTOFsplash10-05aj-1910000000-7b7859c73a972dc697082016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 10V, Positive-QTOFsplash10-000i-0209000000-a89e2594108575220bbb2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 20V, Positive-QTOFsplash10-052r-0915000000-7124c18f1f84cdf81d1e2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 40V, Positive-QTOFsplash10-06sa-6911000000-55458b0290aabf67404b2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 10V, Negative-QTOFsplash10-000i-0009000000-688a65e671067f9875ac2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 20V, Negative-QTOFsplash10-0002-0392000000-e1dde82295b519dbb3392021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5'-Hydroxylornoxicam 40V, Negative-QTOFsplash10-0a4l-9641000000-5e4a4977e1b5fea167c92021-09-24Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4591131
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound54691489
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available

Enzymes

General function:
Involved in peroxidase activity
Specific function:
Mediates the formation of prostaglandins from arachidonate. May have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity.
Gene Name:
PTGS2
Uniprot ID:
P35354
Molecular weight:
68995.625
References
  1. Kothekar V, Sahi S, Srinivasan M, Mohan A, Mishra J: Recognition of cyclooxygenase-2 (COX-2) active site by NSAIDs: a computer modelling study. Indian J Biochem Biophys. 2001 Feb-Apr;38(1-2):56-63. [PubMed:11563332 ]
  2. Yamada M, Niki H, Yamashita M, Mue S, Ohuchi K: Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages. J Pharmacol Exp Ther. 1997 May;281(2):1005-12. [PubMed:9152412 ]
  3. Ozgocmen S, Ardicoglu O, Erdogan H, Fadillioglu E, Gudul H: In vivo effect of celecoxib and tenoxicam on oxidant/ anti-oxidant status of patients with knee osteoarthritis. Ann Clin Lab Sci. 2005 Spring;35(2):137-43. [PubMed:15943176 ]
  4. Yilmaz H, Gurel S, Ozdemir O: The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis. Turk J Gastroenterol. 2005 Sep;16(3):138-42. [PubMed:16245223 ]
  5. Galvao RI, Diogenes JP, Maia GC, Filho EA, Vasconcelos SM, de Menezes DB, Cunha GM, Viana GS: Tenoxicam exerts a neuroprotective action after cerebral ischemia in rats. Neurochem Res. 2005 Jan;30(1):39-46. [PubMed:15756931 ]
  6. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
General function:
Involved in peroxidase activity
Specific function:
May play an important role in regulating or promoting cell proliferation in some normal and neoplastically transformed cells.
Gene Name:
PTGS1
Uniprot ID:
P23219
Molecular weight:
68685.82
References
  1. Yamada M, Niki H, Yamashita M, Mue S, Ohuchi K: Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages. J Pharmacol Exp Ther. 1997 May;281(2):1005-12. [PubMed:9152412 ]
  2. Ozgocmen S, Ardicoglu O, Erdogan H, Fadillioglu E, Gudul H: In vivo effect of celecoxib and tenoxicam on oxidant/ anti-oxidant status of patients with knee osteoarthritis. Ann Clin Lab Sci. 2005 Spring;35(2):137-43. [PubMed:15943176 ]
  3. Lucio M, Ferreira H, Lima JL, Reis S: Interactions between oxicams and membrane bilayers: an explanation for their different COX selectivity. Med Chem. 2006 Sep;2(5):447-56. [PubMed:17017983 ]
  4. Lora M, Morisset S, Menard HA, Leduc R, de Brum-Fernandes AJ: Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin. Prostaglandins Leukot Essent Fatty Acids. 1997 May;56(5):361-7. [PubMed:9175172 ]
  5. Kothekar V, Sahi S, Srinivasan M, Mohan A, Mishra J: Recognition of cyclooxygenase-2 (COX-2) active site by NSAIDs: a computer modelling study. Indian J Biochem Biophys. 2001 Feb-Apr;38(1-2):56-63. [PubMed:11563332 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.
Gene Name:
CYP2C9
Uniprot ID:
P11712
Molecular weight:
55627.365
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Pelkonen O, Maenpaa J, Taavitsainen P, Rautio A, Raunio H: Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica. 1998 Dec;28(12):1203-53. [PubMed:9890159 ]
  3. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]